Crnković-Mertens I - Search Results

1

The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.

Crnković-Mertens I, Muley T, Meister M, Hartenstein B, Semzow J, Butz K, Hoppe-Seyler F. Crnković-Mertens I, et al. Lung Cancer. 2006 Nov;54(2):135-42. doi: 10.1016/j.lungcan.2006.07.018. Epub 2006 Sep 11. Lung Cancer. 2006. PMID: 16965834

2

Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene.

Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Crnkovic-Mertens I, et al. Oncogene. 2003 Nov 13;22(51):8330-6. doi: 10.1038/sj.onc.1206973. Oncogene. 2003. PMID: 14614456

3

Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells.

Crnković-Mertens I, Semzow J, Hoppe-Seyler F, Butz K. Crnković-Mertens I, et al. J Mol Med (Berl). 2006 Mar;84(3):232-40. doi: 10.1007/s00109-005-0021-5. Epub 2005 Dec 31. J Mol Med (Berl). 2006. PMID: 16437214

4

Isolation of peptides blocking the function of anti-apoptotic Livin protein.

Crnković-Mertens I, Bulkescher J, Mensger C, Hoppe-Seyler F, Hoppe-Seyler K. Crnković-Mertens I, et al. Cell Mol Life Sci. 2010 Jun;67(11):1895-905. doi: 10.1007/s00018-010-0300-3. Epub 2010 Feb 23. Cell Mol Life Sci. 2010. PMID: 20177953 Free PMC article.

5

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.

Crnković-Mertens I, Wagener N, Semzow J, Gröne EF, Haferkamp A, Hohenfellner M, Butz K, Hoppe-Seyler F. Crnković-Mertens I, et al. Cell Mol Life Sci. 2007 May;64(9):1137-44. doi: 10.1007/s00018-007-6510-7. Cell Mol Life Sci. 2007. PMID: 17437058 Free PMC article.

6

Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.

Wagener N, Crnković-Mertens I, Vetter C, Macher-Göppinger S, Bedke J, Gröne EF, Zentgraf H, Pritsch M, Hoppe-Seyler K, Buse S, Haferkamp A, Autschbach F, Hohenfellner M, Hoppe-Seyler F. Wagener N, et al. Among authors: crnkovic mertens i. Br J Cancer. 2007 Nov 5;97(9):1271-6. doi: 10.1038/sj.bjc.6604028. Epub 2007 Oct 30. Br J Cancer. 2007. PMID: 17968430 Free PMC article.

7

Peptide aptamers: specific inhibitors of protein function.

Hoppe-Seyler F, Crnkovic-Mertens I, Tomai E, Butz K. Hoppe-Seyler F, et al. Among authors: crnkovic mertens i. Curr Mol Med. 2004 Aug;4(5):529-38. doi: 10.2174/1566524043360519. Curr Mol Med. 2004. PMID: 15267224 Review.

8

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells.

Wagener N, Holland D, Bulkescher J, Crnković-Mertens I, Hoppe-Seyler K, Zentgraf H, Pritsch M, Buse S, Pfitzenmaier J, Haferkamp A, Hohenfellner M, Hoppe-Seyler F. Wagener N, et al. Among authors: crnkovic mertens i. Int J Cancer. 2008 Oct 1;123(7):1545-50. doi: 10.1002/ijc.23683. Int J Cancer. 2008. PMID: 18623083

9

High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.

Haferkamp A, Bedke J, Vetter C, Pritsch M, Wagener N, Buse S, Crnkovic-Mertens I, Hoppe-Seyler K, Macher-Goeppinger S, Hoppe-Seyler F, Autschbach F, Hohenfellner M. Haferkamp A, et al. Among authors: crnkovic mertens i. BJU Int. 2008 Dec;102(11):1700-6. doi: 10.1111/j.1464-410X.2008.07910.x. Epub 2008 Sep 18. BJU Int. 2008. PMID: 18990137

10

Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity.

Butz K, Denk C, Fitscher B, Crnkovic-Mertens I, Ullmann A, Schröder CH, Hoppe-Seyler F. Butz K, et al. Oncogene. 2001 Oct 4;20(45):6579-86. doi: 10.1038/sj.onc.1204805. Oncogene. 2001. PMID: 11641783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters